CME

Unpublished
ICS Members Only
Join ICS Sign in
{{CC.VideoPaywallHeaderText}}
{{CC.VideoPaywalButtonText}} Sign in
Restricted Video
Sign in
CME

Jointly provided by Postgraduate Institute for Medicine and International Continence Society

Request for Meeting Credit and ICS 2018 Evaluation

  1. Go to CME University at: www.cmeuniversity.com
  2. Create New Account or Login
  3. Once logged in, click on "Find Post-test/Evaluation by Course" at the top of the page
  4. Type in “13509” in the box, and hit enter
  5. Click on the activity title “48th Annual Meeting of International Continence Society”
  6. Follow the instructions and complete the online evaluation
  7. Obtain your CME certificate to download and/or print for your files

Upon completion of the online Evaluation form, you will have immediate access to a CME certificate to print or save for your files. You can save your certificate by selecting the "Save" option on the print screen. If you have any questions regarding the CME certification for this activity, please contact the CME provider Postgraduate Institute for Medicine (PIM) at:information@pimed.com.

Target Audience
This activity is intended for urologists, gynaecologists, neurologists, nurses, physical therapists, basic scientists and physiologists delivering primary care to adults.

Educational Objectives
After completing this activity, the participant should be better able to:

• Describe common congenital genitourinary (GU) anomalies and their effects in women during different stages of life.
• Discuss pregnancy-related musculoskeletal tissue changes and injuries with a focus on the pelvic floor muscle.
• Demonstrate how to perform and interpret integrated total pelvic floor ultrasound.
• Apply the latest data in the diagnosis and treatment of nocturia.
• Describe research and exchange of knowledge about the clinical entity of sexual dysfunction.
• Summarize the most up-to-date evidence regarding the incidence, pathophysiology, clinical diagnosis, anorectal investigations, short
term and long term bowel dysfunction.
• Address individual needs in compliance with their Continuous Professional Development (CPD) plan.

Programme Agenda and Faculty
Please view the agenda with registration and break times including faculty here.

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and International Continence Society. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 27.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 27.5 contact hours.

Conversion of credits
The American Medical Association (AMA) has an agreement of mutual recognition of CME credit with the European Union of Medical Specialists (UEMS). Under the terms of this agreement the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, will convert CME credit for live activities certified by the AMA. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should submit their accreditation certificate to the respective medical accreditation authority who will convert their credits to national credits.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Disclosure and resolution of personal conflicts of Interest
In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest resolved. Disclosure is made to participants prior to the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event.

Please click here for disclosure information.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

28/09/2024 02:32:12  14973
Register now